{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:23:46Z","timestamp":1793741026816,"version":"4.6.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biomaterials.2023.122291","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T11:24:45Z","timestamp":1692530685000},"page":"122291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Long-term and liver-selected ginsenoside C\u2013K nanoparticles retard NAFLD progression by restoring lipid homeostasis"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8045-5819","authenticated-orcid":false,"given":"Chunyan","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-6620","authenticated-orcid":false,"given":"Guoping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-7143","authenticated-orcid":false,"given":"Yiqiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biomaterials.2023.122291_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.biomaterials.2023.122291_bib2","first-page":"1","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","author":"Yip","year":"2022","journal-title":"Hepatology (Baltimore, Md"},{"issue":"10215","key":"10.1016\/j.biomaterials.2023.122291_bib3","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"6590","key":"10.1016\/j.biomaterials.2023.122291_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122291_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.biomaterials.2023.122291_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2018069118","article-title":"Active p38\u03b1 causes macrovesicular fatty liver in mice","volume":"118","author":"Darlyuk-Saadon","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1470-2045(13)70081-0","article-title":"Ginseng: panacea among herbal remedies?","volume":"14","author":"Ramaswami","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41368-022-00157-5","article-title":"The osteogenesis of Ginsenoside Rb1 incorporated silk\/micro-nano hydroxyapatite\/sodium alginate composite scaffolds for calvarial defect","volume":"14","author":"Wu","year":"2022","journal-title":"Int. J. Oral Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1478-3231.2005.01068.x","article-title":"Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury","volume":"25","author":"Lee","year":"2005","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122291_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/biom10071028","article-title":"Ginsenoside compound K: insights into recent studies on pharmacokinetics and health-promoting activities","volume":"10","author":"Sharma","year":"2020","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122291_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/cpdd.949","article-title":"Pharmacokinetics of ginsenoside compound K from a compound K fermentation product, CK-30, and from red ginseng extract in healthy Korean subjects","volume":"10","author":"Ban","year":"2021","journal-title":"Clinical Pharmacology in Drug Development"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib12","first-page":"1825","article-title":"Functional characterization of organoids derived from irreversibly damaged liver of patients with","volume":"74","author":"McCarron","year":"2021","journal-title":"NASH"},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122291_bib13","first-page":"808","article-title":"A randomized trial of albumin infusions in hospitalized patients with","volume":"384","author":"China","year":"2021","journal-title":"Cirrhosis"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","article-title":"Acetyl-CoA derived from hepatic peroxisomal \u03b2-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation","volume":"79","author":"He","year":"2020","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122291_bib15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/cr.2014.28","article-title":"Production of bioactive ginsenoside compound K in metabolically engineered yeast","volume":"24","author":"Yan","year":"2014","journal-title":"Cell Res."},{"issue":"29","key":"10.1016\/j.biomaterials.2023.122291_bib16","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/22\/29\/295603","article-title":"Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting","volume":"22","author":"Gong","year":"2011","journal-title":"Nanotechnology"},{"issue":"W1","key":"10.1016\/j.biomaterials.2023.122291_bib17","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gky379","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update","volume":"46","author":"Afgan","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biomaterials.2023.122291_bib18","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biomaterials.2023.122291_bib20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2023.122291_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2016.08.037","article-title":"Switchable PDT for reducing skin photosensitization by a NIR dye inducing self-assembled and photo-disassembled nanoparticles","volume":"107","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jhep.2013.11.007","article-title":"Perilipin discerns chronic from acute hepatocellular steatosis","volume":"60","author":"Pawella","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122291_bib25","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122291_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ncb3166","article-title":"Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis","volume":"17","author":"Kaushik","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib29","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/hep.32045","article-title":"Fatty acid synthase-suppressor screening identifies sorting nexin 8 as a therapeutic target for NAFLD","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology (Baltimore, Md"},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"issue":"6331","key":"10.1016\/j.biomaterials.2023.122291_bib32","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.aag1417","article-title":"Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex","volume":"355","author":"Castellano","year":"2017","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/15548627.2021.1961072","article-title":"Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy","volume":"18","author":"Liu","year":"2022","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","article-title":"A central role for mTOR in lipid homeostasis","volume":"18","author":"Lamming","year":"2013","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122291_bib35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/15548627.2020.1725376","article-title":"Cholesterol derivatives induce dephosphorylation of the histone deacetylases Rpd3\/HDAC1 to upregulate autophagy","volume":"17","author":"Wu","year":"2021","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-019-02018-8","article-title":"Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis","volume":"138","author":"Hoepner","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib37","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.gastro.2017.08.012","article-title":"Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease","volume":"153","author":"VanWagner","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122291_bib38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cmet.2022.07.009","article-title":"A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis","volume":"34","author":"Xi","year":"2022","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122291_bib40","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metabol."},{"issue":"9972","key":"10.1016\/j.biomaterials.2023.122291_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"10290","key":"10.1016\/j.biomaterials.2023.122291_bib42","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2023.122291_bib43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fphar.2017.00965","article-title":"Single- and multiple-dose trials to determine the pharmacokinetics, safety, tolerability, and sex effect of oral ginsenoside compound K in healthy Chinese volunteers","volume":"8","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/D1FO03026D","article-title":"Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1\/AMPK pathway in vitro and in vivo","volume":"13","author":"Zhang","year":"2022","journal-title":"Food Funct."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122291_bib45","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2337\/dc10-2299","article-title":"Ginseng and ginsenoside Re do not improve \u03b2-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes","volume":"34","author":"Reeds","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122291_bib46","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3945\/jn.116.235374","article-title":"Compared with powdered lutein, a lutein nanoemulsion increases plasma and liver lutein, protects against hepatic steatosis, and affects lipoprotein metabolism in Guinea Pigs123","volume":"146","author":"Murillo","year":"2016","journal-title":"J. Nutr."},{"key":"10.1016\/j.biomaterials.2023.122291_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbi.2018.04.010","article-title":"Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet","volume":"288","author":"El-Sherbiny","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib48","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41467-023-38165-6","article-title":"Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122291_bib49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122291_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","article-title":"Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease","volume":"161","author":"Fuchs","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122291_bib51","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat\u2013enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmet.2016.06.006","article-title":"Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through Brown and beige adipose tissue function","volume":"24","author":"Mottillo","year":"2016","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","article-title":"Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia","volume":"61","author":"Di Filippo","year":"2014","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122291_bib54","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2017.10.037","article-title":"Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling","volume":"171","author":"Lee","year":"2017","journal-title":"Cell"},{"issue":"6590","key":"10.1016\/j.biomaterials.2023.122291_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1126\/science.abp8276","article-title":"Complex regulation of fatty liver disease","volume":"376","author":"Ginsberg","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122291_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.abb.2007.06.029","article-title":"Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase\/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation","volume":"465","author":"Sidiropoulos","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122291_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13683","article-title":"Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR\u03b3 directs early activation of T cells","volume":"7","author":"Angela","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122291_bib59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2010.10.044","article-title":"Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis","volume":"55","author":"Patsenker","year":"2011","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib60","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cmet.2013.03.003","article-title":"Molecular and genetic crosstalks between mTOR and ERR\u03b1 are key determinants of rapamycin-induced nonalcoholic fatty liver","volume":"17","author":"Chaveroux","year":"2013","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122291_bib61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1254\/jphs.08215FP","article-title":"Rapamycin protects against high fat diet\u2013induced obesity in C57bl\/6J mice","volume":"109","author":"Chang","year":"2009","journal-title":"J. Pharmacol. Sci."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:28:48Z","timestamp":1758907728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961223002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":61,"alternative-id":["S0142961223002995"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122291","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term and liver-selected ginsenoside C\u2013K nanoparticles retard NAFLD progression by restoring lipid homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"122291"}}